Nurse Practitioner in Northfield, VT Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Debra Maloney-evans, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 87 Paine Mountain Drive, Green Mountain Family Practice, Northfield, VT 05663 Phone: 802-485-4161 Fax: 802-485-4163 |
Nancy Peters Sullivan, ARNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 87 Paine Mountain Dr, Northfield, VT 05663 Phone: 802-485-4161 Fax: 802-485-4163 |
Loretta B. Charles, NURSE PRACTITIONER Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 87 Paine Mountain Drive, Green Mountain Family Practice, Northfield, VT 05663 Phone: 802-485-4161 Fax: 802-485-4163 |
Carolyn Simmons Gaeckle, PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 454 Freeman Rd, Northfield, VT 05663 Phone: 302-332-6021 |
News Archive
Young adults with depression symptoms may benefit from computerized avatars
Young adults, in a period of transition, are often reluctant to seek treatment for mental health problems because of the stigma, inadequate insurance coverage and difficulty finding a mental health care provider.
Birner Dental Management Services' 2009 net income up 7.5%
Birner Dental Management Services, Inc., operators of PERFECT TEETH® dental practices, announced results for the year and quarter ended December 31, 2009. For the year ended December 31, 2009, revenue increased $557,000, or 0.9%, to $59.6 million. The Company's earnings before interest, taxes, depreciation, amortization and non-cash expense associated with stock-based compensation ("Adjusted EBITDA") increased $101,000, or 1.5%, to $6.9 million.
Decoding abnormal touch sensitivity in autism spectrum disorders
The inability to tolerate light touch is a telltale feature of autism and one of the disorder's many perplexing symptoms. It has defied treatment, and its precise origins have remained somewhat of a mystery.
Adaptimmune begins Phase I/II study of affinity enhanced T-cell therapy targeting MAGE-A10 in NSCLC patients
Adaptimmune Therapeutics plc, a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it has initiated a Phase I/II study of its affinity enhanced T-cell therapy targeting the MAGE-A10 cancer antigen in patients with locally advanced or metastatic (Stage IIIb or IV) non-small cell lung cancer (NSCLC), the most prevalent type of lung cancer representing approximately 85 percent of lung cancers.
› Verified 7 days ago